超声内镜引导下胆管十二指肠吻合术治疗ERCP失败后恶性远端胆道梗阻:一项回顾性全国分析
这项多中心回顾性分析纳入2016年1月至2020年7月意大利23个中心256例ERCP失败后恶性远端胆道梗阻患者,评估超声内镜引导下胆管十二指肠吻合术(EUS-CDS)置入腔内并列金属支架(LAMS)的技术成功与临床成功。技术成功239/256(93.3%),临床成功230/239(96.2%),25/239例(10.5%)发生不良事件,无致死性不良事件。作者认为EUS-CDS是有效且安全的可行替代方案。
要点
- 技术成功239/256(93.3%),临床成功230/239(96.2%)。
- 25/239例(10.5%)发生不良事件,无致死性不良事件。
- 22例(9.2%)需内镜或放射学再干预处理不良事件。
核心结论
- EUS-CDS置入LAMS在ERCP失败的DMBO患者中在有效性和安全性方面是可行的替代方案,不良事件率可接受。
研究设计与样本
- 多中心回顾性分析,纳入2016年1月至2020年7月意大利23个中心所有ERCP失败后DMBO行EUS-CDS置入LAMS的病例。
- 共纳入256例患者(44.9%为女性),平均年龄73.9±12.6岁。
主要发现
- DMBO最常见病因为胰腺腺癌(75%),其次为壶腹癌(8.6%)和胆管癌(6.6%)。
- 胆总管中位直径17.3±3.9 mm。
- 技术成功239/256(93.3%),临床成功230/239(96.2%)。
- 平均随访151±162天。
- 25/239例(10.5%)发生27起不良事件(3起轻度、21起中度、3起重度),无致死性不良事件。
局限性
- 原文为回顾性分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: EUS-guided choledochoduodenostomy (EUS-CDS) with a lumen-apposing metal stent (LAMS) has been proposed as an alternative procedure in patients with distal malignant biliary obstruction (DMBO) and failed ERCP. METHODS: This multicenter, retrospective analysis included all cases of EUS-CDS with LAMS performed in patients with DMBO and failed ERCP in 23 Italian centers from January 2016 to July 2020. Primary endpoints were technical and clinical success. Secondary endpoints were the assessment of the adverse event (AE) rate and variables associated with technical success. RESULTS: Two hundred fifty-six patients (44.9% women) with a mean age of 73.9 ± 12.6 years were included in the study. The most common etiology of DMBO was pancreatic adenocarcinoma (75%), followed by ampullary cancer (8.6%) and cholangiocarcinoma (6.6%). The common bile duct median diameter was 17.3 ± 3.9 mm. Technical and clinical success were achieved in 239 of 256 (93.3%), and 230 of 239 (96.2%) patients, respectively. The mean follow-up was 151 ± 162 days. Twenty-seven AEs occurred in 25 of 239 patients (10.5%) (3 mild, 21 moderate, and 3 severe). No fatal AEs occurred. Reinterventions to manage AEs with endoscopic or radiologic procedures occurred in 22 patients (9.2%). CONCLUSIONS: The results of our study show that EUS-CDS with LAMSs in patients with DMBO and failed ERCP represent a viable alternative in terms of effectiveness and safety with acceptable AE rates. (Clinical trial registration number: NCT03903523.).
引用
- Fugazza A, Fabbri C, Di Mitri R, et al. EUS-guided choledochoduodenostomy for malignant distal biliary obstruction after failed ERCP: a retrospective nationwide analysis. Gastrointest Endosc. 2022. PMID: 34995640. doi:10.1016/j.gie.2021.12.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。